Document is current
Any future updates will be listed below
-
Authors
Tenstad, Olav https://orcid.org/0000-0001-5833-2620
Christakou, Eleni https://orcid.org/0009-0006-4343-7431
Hodneland Nilsson, Linn
Gausdal, Gro
Micklem, David https://orcid.org/0000-0003-2756-2591
Kursula, Petri https://orcid.org/0000-0001-8529-3751
Lorens, James B. https://orcid.org/0000-0003-1797-7902
Reed, Rolf K. https://orcid.org/0000-0001-5607-6416
-
Funding
Funding for this research was provided by:
BerGenBio
Norges Forskningsråd
University of Bergen
- License Information
-
More Information
Article History
Received: 13 March 2024
Accepted: 3 July 2024
First Online: 12 July 2024
Competing interests
: OT holds a patent on labelling procedures of protein with <sup>18</sup>F. JBL and DM are founders and shareholders of BerGenBio ASA. DM and EC are current, and JBL, LHN, GG are former employees of BerGenBio ASA. The animal studies were financed by BerGenBio ASA and the structural studies were financed by BerGenBio ASA and the Research Council of Norway (Grant Number 311399). The remaining authors declare no conflict of interest.
